Compare NAMM & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAMM | LITS |
|---|---|---|
| Founded | 2024 | 2000 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 48.5M |
| IPO Year | N/A | N/A |
| Metric | NAMM | LITS |
|---|---|---|
| Price | $2.70 | $1.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 27.0M | 476.9K |
| Earning Date | 04-23-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $80,348,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $109.93 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.52 | N/A |
| 52 Week Low | $0.91 | $0.95 |
| 52 Week High | $55.00 | $9.00 |
| Indicator | NAMM | LITS |
|---|---|---|
| Relative Strength Index (RSI) | 46.49 | 38.67 |
| Support Level | $2.16 | $0.98 |
| Resistance Level | $2.89 | $1.13 |
| Average True Range (ATR) | 0.93 | 0.08 |
| MACD | -0.27 | -0.00 |
| Stochastic Oscillator | 3.04 | 30.59 |
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.